» Articles » PMID: 25287952

Breakthrough Reactions of Iodinated and Gadolinium Contrast Media After Oral Steroid Premedication Protocol

Overview
Journal BMC Med Imaging
Publisher Biomed Central
Specialty Radiology
Date 2014 Oct 8
PMID 25287952
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue. Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrough reaction; BTR).The purpose of this study was to assess the frequency, type and severity of BTR when following an oral steroid premedication protocol.

Methods: All iodinated and gadolinium contrast-enhanced radiologic examinations between August 2011 and February 2013 for which the premedication protocol was applied in our institution were assessed for BTRs.

Results: The protocol was applied to a total of 252 examinations (153 patients, ages 15-87 years; 63 males, 90 females). Of these, 152 were for prior acute adverse reactions to contrast media, 85 were for a history of bronchial asthma, and 15 were for other reasons. There were 198 contrast enhanced CTs and 54 contrast enhanced MRIs. There were nine BTR (4.5%) for iodinated contrast media, and only one BTR (1.9%) for gadolinium contrast media: eight were mild and one was moderate. No patient who had a mild index reaction (IR) had a severe BTR.

Conclusion: Incidence of BTRs when following the premedication protocol was low. This study by no means proves the efficacy of premedication, but provides some support for following a premedication protocol to improve safety of contrast-enhanced examinations when prior adverse reactions are mild, or when there is a history of asthma.

Citing Articles

Cross-reactivity in hypersensitivity reactions to contrast agents: new classification and guide for clinical practice.

Vega F, van de Ven A, van der Molen A Eur Radiol. 2024; 34(12):7583-7588.

PMID: 38937294 DOI: 10.1007/s00330-024-10872-8.


Immediate hypersensitivity reactions to iodinated contrast media despite drug prophylaxis-a comparative retrospective cohort study of breakthrough reactions in Bern (Switzerland) and Seoul (South Korea).

Beiner L, Jeong J, Kang D, Lombardo P, Kang H, Boehm I Quant Imaging Med Surg. 2024; 14(5):3326-3338.

PMID: 38720860 PMC: 11074757. DOI: 10.21037/qims-23-912.


Balloon-occlusion Retrograde Transvenous Obliteration Using Gadoteridol As an Alternative Contrast Agent in a Patient with Iodine Allergy.

Iwasa T, Adachi S, Oyama Y, Suzuki Y, Mabuchi M, Nakamura H Intern Med. 2023; 63(8):1099-1103.

PMID: 37690844 PMC: 11081900. DOI: 10.2169/internalmedicine.2481-23.


Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis.

Hsieh C, Wu S, Kosik R, Huang Y, Chan W Diagnostics (Basel). 2022; 12(7).

PMID: 35885578 PMC: 9320945. DOI: 10.3390/diagnostics12071673.


Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.

Maloney E, Iyer R, Phillips G, Menon S, Lee J, Callahan M Pediatr Radiol. 2019; 49(4):433-447.

PMID: 30923875 DOI: 10.1007/s00247-018-4306-6.


References
1.
Kim S, Lee S, Lee S, Kang H, Park H, Kim S . Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea. Eur J Radiol. 2010; 80(2):363-7. DOI: 10.1016/j.ejrad.2010.06.014. View

2.
Wang C, Cohan R, Ellis J, Caoili E, Wang G, Francis I . Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol. 2008; 191(2):409-15. DOI: 10.2214/AJR.07.3421. View

3.
Dillman J, Ellis J, Cohan R, Strouse P, Jan S . Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication. AJR Am J Roentgenol. 2007; 190(1):187-90. DOI: 10.2214/AJR.07.2718. View

4.
Kobayashi D, Takahashi O, Ueda T, Arioka H, Akaishi Y, Fukui T . Asthma severity is a risk factor for acute hypersensitivity reactions to contrast agents: a large-scale cohort study. Chest. 2012; 141(5):1367-1368. DOI: 10.1378/chest.11-3143. View

5.
Morgan D, Spann J, Lockhart M, Winningham B, Bolus D . Assessment of adverse reaction rates during gadoteridol-enhanced MR imaging in 28,078 patients. Radiology. 2011; 259(1):109-16. DOI: 10.1148/radiol.10100906. View